AL
Anna ladogana
Istituto Superiore di Sanità, Università Cattolica del Sacro Cuore, Catholic University Rome Italy
Research areas: Biochemistry, Genetics and Molecular Biology · Molecular Biology · Prion Diseases and Protein Misfolding · Amyloidosis: Diagnosis, Treatment, Outcomes · Alzheimer's disease research and treatments
0000-0002-7504-6906
Employment
-
Istituto Superiore di Sanità Head of research1962 - Present
Education
-
Università Cattolica del Sacro Cuore Board in Clinical Pathology1988 - 1992
-
Catholic University Rome Italy MD1981 - 1987
Projects & Funding
-
Development and validation of a panel of easily-accessible diagnostic and prognostic biofluid biomarkers of synucleinopathies Ministero della Salute2024 - 2027
-
A strain-based comprehensive strategy to reveal human prion diseases potentially linked to animal prions Ministero della Salute2019 - 2023
-
“Early diagnosis of Alzheimer’s diseases: role of biological, functional and clinical markers Ministero della Salute2006 - 2009
-
“ Development of a common database on clinical, instrumental, and risk factors in human TSE based on web technology” Sixth Framework Programme2005 - 2008
-
Ricerca di fattori endogene o esogeni diversi dalla PrP coinvolti nell’etiopatogenesi delle TSE” Ministero della Salute2002 - 2003
Publications (84)
- “Polyradiculoneuritis” as an Atypical Clinical Presentation of Creutzfeldt–Jakob Disease: A Case Report and Review of Literature Save
- Clinical phenotype associated with A118V mutation of PRPN gene Save
- Sciatic Integrity Is Necessary for Fast and Efficient Scrapie Infection After Footpad Injection Save
- Creutzfeldt-Jakob disease in a man surviving COVID-19: disentangling a casual or causal association by neuropathology Save
- Creutzfeldt–Jakob disease and other prion diseases Save
- Prodynorphin and Proenkephalin in Cerebrospinal Fluid of Sporadic Creutzfeldt–Jakob Disease Save
- Phenotypic diversity of genetic Creutzfeldt-Jakob disease: a histo-molecular-based classification. Save
- Diagnostic and prognostic performance of CSF α-synuclein in prion disease in the context of rapidly progressive dementia. Save
- The importance of ongoing international surveillance for Creutzfeldt–Jakob disease Save
- Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease. Save
- Ring trial of 2nd generation RT-QuIC diagnostic tests for sporadic CJD. Save
- Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study. Save
- Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion disease. Save
- Genetic Creutzfeldt-Jakob disease in Sardinia: a case series linked to the PRNP R208H mutation due to a single founder effect. Save
- Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies. Save
- Diagnostic Accuracy of Prion Disease Biomarkers in Iatrogenic Creutzfeldt-Jakob Disease. Save
- Correction to: Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies (Acta Neuropathologica, (2020), 140, 1, (49-62), 10.1007/s00401-020-02160-8) Save
- α-Synuclein RT-QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies. Save
- Spatial Epidemiology of Sporadic Creutzfeldt-Jakob Disease in Apulia, Italy. Save
- Clinicopathological features of the rare form of Creutzfeldt-Jakob disease in R208H-V129V PRNP carrier. Save